Moreover, TGF-βRII-NKG2D receptor expression promotes NK92 chemotaxis to the TGF-β-expressing tumor cells and inhibits the differentiation of CD4+ T cells to Tregs (264). This evidence concerns the gene TGFB1 and neoplasm.